Inpatient hyperglycemia management: A practical review for primary medical and surgical teams

Cleveland Clinic Journal of Medicine

Volumn 83, Issue , 2016, Pages 34-43

  Lansang, M Cecilia ^a,b   Umpierrez, Guillermo E ^c  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN DERIVATIVE;

CLINICAL PROTOCOL; DISEASE MANAGEMENT; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE; PRACTICE GUIDELINE; PROCEDURES;

CLINICAL PROTOCOLS; CRITICAL CARE; DISEASE MANAGEMENT; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULINS; PRACTICE GUIDELINES AS TOPIC;

EID: 85026330179     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/CCJM.83.S1.06     Document Type: Article

References (47)

1. 1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978–982.
2. 2. Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009; 37:3001–3009.
3. 3. Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyper-glycemia and risk of adverse events among patients with and without diabetes. Ann Surg 2015; 261:97–103.
4. 4. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011; 34:256–261.
5. 5. Murad MH, Coburn JA, Coto-Yglesias F, et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012; 97:49–58.
6. 6. Schroeder JE, Liebergall M, Raz I, et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes Metab Res Rev 2012; 28:71–75.
7. 7. Clement S, Braithwaite SS, Magee MF, et al; American Diabetes Association in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27:553–591.
8. 8. Inzucchi SE. Clinical practice: Management of hyperglycemia in the hospital setting. N Engl J Med 2006; 355:1903–1911.
9. 9. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359–1367.
10. 10. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449–461.
11. 11. NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283–1297.
12. 12. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180:821–827.
13. 13. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32:1119–1131.
14. 14. Umpierrez G, Cardona S, Pasquel F, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG Trial. Diabetes Care 2015; 38:1665–1672.
15. 15. Montori VM, Bistrian BR, McMahon MM. Hyperglycemia in acutely ill patients. JAMA 2002; 288:2167–2169.
16. 16. Ramos M, Khalpey Z, Lipsitz S, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg 2008; 248:585–591.
17. 17. American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010; 33(suppl 1):S11–S61.
18. 18. Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94:709–728.
19. 19. Krikorian A, Ismail-Beigi F, Moghissi ES. Comparisons of different insulin infusion protocols: a review of recent literature. Current Opin Clin Nutr Metab Care 2010; 13:198–204.
20. 20. Umpierrez GE, Hor T, Smiley D, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab 2009; 94:564–569.
21. 21. Smith WD, Winterstein AG, Johns T, Rosenberg E, Sauer BC. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm 2005; 62:714–719.
22. 22. Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med 2009; 4:3–15.
23. 23. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009; 32:1153–1157.
24. 24. Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes—the ‘dead in bed’ syndrome revisited. Diabetologia 2009; 52:42–45.
25. 25. Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med 2011; 124:1028–1035.
26. 26. Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012; 97:16–38.
27. 27. Dhatariya K, Levy N, Kilvert A, et al; Joint British Diabetes Societies. NHS diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med 2012; 29:420–433.
28. 28. Lazar HL, McDonnell M, Chipkin SR, et al; Society of Thoracic Surgeons Blood Glucose Guideline Task Force. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009; 87:663–669.
29. 29. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40:3251–3276.
30. 30. Hirsch IB. Sliding scale insulin—time to stop sliding. JAMA 2009; 301:213–214.
31. 31. Dobri GA, Lansang MC. How should we manage insulin therapy before surgery? Cleve Clin J Med 2013; 80:702–704.
32. 32. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007; 30:2181–2186.
33. 33. Bueno E, Benitez A, Rufinelli JV, et al. Basal-bolus regimen with insulin analogs versus human insulin in medical patients with type 2 diabetes: a randomized controlled trial in Latin America. Endocr Pract 2015; 21:807–813.
34. 34. Umpierrez GE, Smiley D, Hermayer K, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care 2013; 36:2169–2174.
35. 35. American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes 2015; 33:97–111.
36. 36. Rubin DJ, Rybin D, Doros G, McDonnell ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care 2011; 34:1723–1728.
37. 37. Umpierrez GE, Gianchandani R, Smiley D, et al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care 2013; 36:3430–3435.
38. 38. Munt R, Hutton A. Type 1 diabetes mellitus (T1DM) self management in hospital; is it possible? A literature review. Contemp Nurse 2012; 40:179–193.
39. 39. American Diabetes Association. Diabetes care in the hospital, nursing home, and skilled nursing facility. Diabetes Care 2015; 38(suppl):S80–S85.
40. 40. Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care 2005; 28:2267–2279.
41. 41. Pasquel FJ, Spiegelman R, McCauley M, et al. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care 2010; 33:739–741.
42. 42. Umpierrez GE, Spiegelman R, Zhao V, et al. A double-blind, randomized clinical trial comparing soybean oil-based versus olive oil-based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition. Crit Care Med 2012; 40:1792–1798.
43. 43. RNCOS Industry Research Solutions. US to dominate the global insulin pump market—April 28, 2011. www.rncos.com/Press_ Releases/US-to-Dominate-the-Global-Insulin-Pump-Market.htm. Accessed March 16, 2016.
44. 44. Lansang MC, Modic MB, Sauvey R, et al. Approach to the adult hospitalized patient on an insulin pump. J Hosp Med 2013; 8:721–727.
45. 45. Tripathy PR, Lansang MC. U-500 regular insulin use in hospitalized patients. Endocr Pract 2015; 21:54–58.
46. 46. Umpierrez GE, Reyes D, Smiley D, et al. Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care 2014; 37:2934–2939.
47. 47. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011; 154:260–267.